Zensar Q2 results: net profit rises 4.4% to Rs 190.2 crore
Zensar Technologies reported consolidated revenue of Rs 1,585.2 crore and net profit of Rs 190.2 crore for the quarter ended 30 September 2026, in a filing with the National Stock Exchange.
Key points
- Zensar Technologies said consolidated net profit for the quarter ended 30 September 2026 was Rs 190.2 crore, up 4.4% from a year earlier.
- Consolidated revenue from operations was Rs 1,585.2 crore, up 11.5% year on year and 5.1% from the previous quarter.
- The company also said its board approved merging M3BI India Private Limited into Zensar from 1 April 2027, subject to approvals.
Zensar Technologies said in a filing with the National Stock Exchange that its consolidated net profit for the quarter ended 30 September 2026 (Q2 FY27) was Rs 190.2 crore, up 4.4% from Rs 182.2 crore a year earlier. Consolidated revenue from operations was Rs 1,585.2 crore. The board approved the results on 28 October 2026.
What Happened
The company's filing with the National Stock Exchange gives unaudited consolidated results, reviewed by its statutory auditors. All figures below are consolidated.
Revenue from operations was Rs 1,585.2 crore. That is 11.5% higher than the Rs 1,421.3 crore in the September 2025 quarter and 5.1% higher than the Rs 1,508.3 crore in the June 2026 quarter.
Net profit for the period was Rs 190.2 crore. That is 4.4% above the year-earlier figure and 3.5% above the Rs 183.8 crore of the June 2026 quarter. Profit before tax was Rs 251.9 crore, against Rs 240.2 crore a year earlier. Basic earnings per share were Rs 8.33 and diluted earnings per share were Rs 8.28.
For the half year ended 30 September 2026, revenue from operations was Rs 3,093.5 crore, up 10.2% from Rs 2,806.3 crore, and net profit was Rs 374.0 crore, up 2.7% from Rs 364.2 crore.
By segment, Digital and Application Services contributed Rs 1,244.6 crore of the quarter's revenue and Cloud Infrastructure and Security contributed Rs 340.6 crore.
Separately, the filing says the board approved the merger of M3BI India Private Limited with Zensar Technologies Limited from 1 April 2027, subject to the necessary approvals. It also notes that two group entities, BridgeView Life Sciences, LLC and M3BI LLC, were merged with Zensar Technologies Inc. during the quarter, with no impact on the consolidated results because they were within the group.
What It Means
Revenue grew faster than profit in the quarter. Total expenses rose 11.8% from a year earlier, to Rs 1,375.6 crore from Rs 1,230.2 crore, which is slightly faster than revenue grew. Employee benefits expense was Rs 933.6 crore and subcontracting costs were Rs 277.7 crore, according to the filing.
Quarterly results are unaudited and are reviewed, not audited, by the company's auditors. Readers who follow the company can compare these figures with the full filing on the National Stock Exchange website. This report states what the company disclosed and does not forecast future results.
Source: Company filing on NSE
Sources & Citations
- Company filing on NSE — National Stock Exchange of India